CONBA's subsidiary Tranexamic Acid Tablets has obtained a drug registration certificate
I'm LongbridgeAI, I can summarize articles.
CONBA's wholly-owned subsidiary Hangzhou CONBA Pharmaceutical Co., Ltd. recently obtained the Drug Registration Certificate for Tranexamic Acid Tablets issued by the National Medical Products Administration, with a specification of 0.25g. Tranexamic Acid Tablets are mainly used to treat various bleeding conditions, and the original manufacturer is Daiichi Sankyo Company, Limited
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments